Stock 300110 HUAREN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Huaren Pharmaceutical Co., Ltd.

Equities

300110

CNE100000SW1

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 15/05/2024 am IST 		5-day change 1st Jan Change
3.63 CNY -2.42% Intraday chart for Huaren Pharmaceutical Co., Ltd. -3.20% -13.98%
24/04 Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24/04 Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Huaren Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Huaren Pharma's Unit Gets Nod for Medical Device
Huaren Pharma's Unit Gets Nod to Add Specifications to Antibiotic Product
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Huaren Pharmaceutical Co., Ltd. Announces Director Appointments
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Huaren Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 12 July 2023
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Huaren Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Huaren Pharma Appoints Executive President
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Huaren Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 17, 2022
Huaren Pharmaceutical Co., Ltd. Approves Board Appointments
Huaren Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2021
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Huaren Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300110 Stock
  4. News Huaren Pharmaceutical Co., Ltd.
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW